Project Number PCTR-16-383171 Agency/Funding Organization Alzheimer's Association Funding Year 2016 View Full Project Details for Phase 1 Testing of a Muscarinic M1 PAM for Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator NEWHOUSE, PAUL A. Principal Investigator First Name PAUL A. Principal Investigator Last Name NEWHOUSE Awardee Organization VANDERBILT UNIVERSITY Awardee State Tennessee Contact PI Country United States Project Detail Funding Opportunity Announcement PA 2016: PCT RFA FY Overall Cost $1,071,130 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Snyder, Heather hsnyder@alz.org
